Join
Live feed
·
INSIDERFilingvia Quantisnow
Citius Oncology Inc. logo

Director Mayersohn Joel David acquired 21,228 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CTOR· Citius Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTOR (Citius Oncology Inc.) and more on Quantisnow.

Director Mayersohn Joel David acquired 21,228 shares (SEC Form 4) | Quantisnow